Kathleen D. Scott Silverback Therapeutics, Inc. (SBTX) insider trading activity

Kathleen D. Scott is Chief Financial Officer of Silverback Therapeutics, Inc.. Currently has a direct ownership of 7,424 shares of SBTX, which is worth approximately $0. The most recent transaction as insider was on May 20, 2025, when has been sold 50,000 shares (Common Stock) at a price of $14.1 per share, resulting in proceeds of $705,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 7.42K

50.01% 3M change

n/a 12M change

Total Value Held $0

Kathleen D. Scott Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 20 2025	SELL Open market or private sale	$705,000 $14.1 p/Share	50,000 Reduced 87.07%	7,424 Common Stock
May 20 2025	BUY Exercise of conversion of derivative security	$75,000 $1.5 p/Share	50,000 Added 46.54%	57,424 Common Stock
Oct 16 2024	SELL Open market or private sale	$200,000 $16.0 p/Share	12,500 Reduced 71.64%	4,949 Common Stock
Oct 16 2024	BUY Exercise of conversion of derivative security	$18,750 $1.5 p/Share	12,500 Added 41.74%	17,449 Common Stock
Aug 20 2024	SELL Open market or private sale	$200,000 $16.0 p/Share	12,500 Reduced 48.64%	13,199 Common Stock
Aug 20 2024	BUY Exercise of conversion of derivative security	$18,750 $1.5 p/Share	12,500 Added 32.72%	25,699 Common Stock

Also insider at

DRMA

Dermata Therapeutics, Inc. Healthcare

GFOR-WT

Graf Acquisition Corp. IV

Director

KDS

Kathleen D. Scott

Chief Financial Officer

San Diego, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SBTX shares.

Notify only if

Value

Insider Trading

Get notified when an Silverback Therapeutics, Inc. insider buys or sells SBTX shares.

Notify only if

Operation

Value

Type

News

Receive news related to Silverback Therapeutics, Inc.

Track Activities on SBTX

Account